Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies

Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies

Introduction: The efficacy and safety of switching P2Y12 receptor antagonists in patients admitted for acute coronary syndrome (ACS) remain unclear. We assessed the short-term clinical outcomes (in-hospital and within 30 days) of switching P2Y12 inhibitor (P2Y12I) drugs versus maintaining the same r...

Full description

Bibliographic Details
Main Authors: Enrico Cerrato, Matteo Bianco, Akshay Bagai, Leonardo De Luca, Simone Biscaglia, Alessia Luciano, Paola Destefanis, Giorgio Quadri, Ilaria Meynet, Carol Gravinese, Alessandra Chinaglia, Shaun G. Goodman, Roberto Pozzi, Gianluca Campo, Ferdinando Varbella
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:International Journal of Cardiology: Heart & Vasculature
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906718301271

Internet

http://www.sciencedirect.com/science/article/pii/S2352906718301271

Similar Items